期刊文献+

美国FDA 1999年批准新药介绍

Introduction to the Drugs Approved in USA in 1999
下载PDF
导出
摘要 创新药物上市是一件非常复杂的事,它涉及很多方面。了解国外目前上市的药物是使我们掌握国外新药动态的一个最直接的方法、深入了解上市药物的发现过程、作用机理有助于启发我们开发自己的新药。 To bring a new chemical entity to market is a very complex process, it involves many aspects. In order to master the recent development of new drugs the direct way is to find what drugs were approved in other countries in recent years. It would be helpful for us to develop our new drugs by understanding the discovery processes and the mechanism of action of new drugs.
出处 《中国医药导刊》 2000年第6期32-34,共3页 Chinese Journal of Medicinal Guide
  • 相关文献

参考文献1

二级参考文献7

  • 1A. T. Melia,J. Zhi,R. Zelasko,D. Hartmann,C. Güzelhan,R. Guerciolini,J. Odink.The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers[J].European Journal of Clinical Pharmacology (-).1998(9-10)
  • 2L. F. Van Gaal,J. I. Broom,G. Enzi,H. Toplak.Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study[J].European Journal of Clinical Pharmacology.1998(2)
  • 3Hollander PA,Elbein SC,Hirsch IB,et al.Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes[].Diabetes Care.1998
  • 4Sjostrom L,McCarthy WJ,Lekkerkerker.Orlistat and weight loss (letter)[].The Lancet.1998
  • 5Bray GA.Obesity: a time bomb to be defused[].The Lancet.1998
  • 6Sjostrom L,Rissanen Aila,Andersen T,et al.Randomised placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients[].The Lancet.1998
  • 7Davidson MH,Hauptman J,DiGirolamo M,et al.Weight control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat[].The Journal of The American Medical Association.1999

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部